PTC to sell roy­al­ties on block­buster SMA drug Evrys­di for up to $1.5B

PTC Ther­a­peu­tics on Thurs­day an­nounced an agree­ment with Roy­al­ty Phar­ma to mon­e­tize up to $1.5 bil­lion of the roy­al­ty stream for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA